ADx NeuroSciences is an R&D driven company specialized in the development of neurodegenerative biomarkers. Its expertise is used by pharmaceutical and diagnostic companies for the conception, development, production, and worldwide commercialization of novel biomarkers.

https://adxneurosciences.com/

ADx NeuroSciences

Fujirebio is a global leader in the field of in vitro diagnostics (IVD) testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variety of disease states.

https://www.fujirebio.com/

Gent

Fujirebio

H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and ADx NeuroSciences NV today announced the acquisition of ADx NeuroSciences by Fujirebio for 40 million euros. Pending the satisfaction of customary closing conditions, the deal is expected to close in July 2022. ADx NeuroSciences becomes a wholly owned subsidiary of Fujirebio Europe NV.

Fujirebio Acquires Adx Neurosciences And Confirms Its Intentions To Bring Better And Earlier Neurodegenerative Disease Diagnostic Solutions To The Global Diagnostics Industry

Fujirebio Acquires Adx Neurosciences And Confirms Its Intentions To Bring Better And Earlier Neurodegenerative Disease Diagnostic Solutions To The Global Diagnostics Industry

Fujirebio Acquires Adx Neurosciences And Confirms Its Intentions To Bring Better And Earlier Neurodegenerative Disease Diagnostic Solutions To The Global Diagnostics Industry

Company Info